Saturday 17 October 2026
Export TLPH’s income statement to Excel — free account
Talphera, Inc.
TLPH Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue fell 99.6%, EPS grew 40.0% and free cash flow fell 33.1%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.
1.08
0.01
+0.93%
Follow TLPH
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | — | 0.00 |
Piotroski F-Score |
1 | 2 | 4 | 1 | 4 | 4 | 3 | 4 | — | — |
P/S ratio |
6.66 | 12.02 | 62.73 | 72.99 | 19.52 | 23.82 | 9.26 | 11.69 | — | 113.49 |
Altman Z-Score |
(2.71) | (5.80) | (3.35) | (6.52) | (10.17) | (9.15) | (13.61) | (31.77) | — | (20.73) |
Altman Z″-Score (non-manufacturers) |
(5.06) | (12.32) | (6.27) | (14.35) | (23.31) | (20.56) | (30.43) | (71.94) | — | (49.59) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Beneish M-Score |
(1.19) | — | — | — | — | — | — | — | — | — |
P/Operating CF |
(11.20) | (14.40) | (15.01) | (11.80) | (16.71) | (8.39) | (3.03) | (2.67) | — | (19.85) |
P/B ratio |
0.00 | 0.00 | 31.73 | 0.00 | 0.00 | 0.00 | 0.75 | 0.75 | — | 2.84 |
Price to Tangible BV |
0.00 | 0.00 | 31.73 | 0.00 | 0.00 | 0.00 | 0.75 | 0.75 | — | 2.84 |
EV/Sales |
3.27 | 6.85 | 19.16 | 55.08 | 15.64 | 12.17 | 2.27 | 8.34 | — | 80.58 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
EV/Operating CF |
(1.93) | (1.84) | (1.42) | (2.46) | (2.20) | (1.14) | (0.14) | (0.43) | — | (3.02) |
EV/FCF |
(1.71) | (1.70) | (1.38) | (2.31) | (2.10) | (1.08) | (0.13) | (0.51) | — | (3.93) |
Quick Ratio |
8.45 | 4.54 | 6.66 | 4.89 | 2.47 | 2.53 | 1.51 | 2.08 | 3.35 | 5.35 |
Current Ratio |
8.74 | 4.64 | 6.78 | 5.27 | 2.66 | 2.73 | 1.78 | 2.57 | 3.56 | 5.49 |
Net Debt/EBITDA |
1.96 | 1.12 | 2.67 | 0.78 | 0.54 | 0.97 | 0.65 | 0.57 | 0.58 | 1.50 |
Debt/Assets |
21.55% | 25.28% | 9.95% | 27.53% | 33.00% | 17.72% | 11.29% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(4.04) | (0.52) | 2.82 | (0.61) | (0.39) | (0.38) | 0.25 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.15 | 0.09 | 0.02 | 0.02 | 0.07 | 0.04 | 0.03 | 0.02 | 0.00 | 0.00 |
Operating CF/Net income |
0.68 | 0.58 | 0.62 | 0.96 | 0.95 | 0.85 | (0.67) | 0.95 | 0.98 | 0.80 |
Capex/Depreciation |
(1.81) | (1.38) | (1.42) | (2.08) | (1.00) | (0.93) | (1.25) | 9.14 | 0.00 | 0.00 |
Interest Coverage |
(2.63) | (2.76) | (2.84) | (45.25) | 8,192.60 | 48.15 | (22.67) | (126.04) | (38.71) | — |
| (310.75%) | 246.18% | 292.34% | 286.51% | 83.11% | 76.60% | (601.31%) | (102.44%) | (117.65%) | (114.16%) | |
| (37.89%) | (58.68%) | (48.09%) | (50.25%) | (51.23%) | (48.69%) | 67.52% | (54.20%) | (67.32%) | (59.60%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (246.80%) | (223.45%) | 0.00% | 0.00% |
Return on Tangible Assets |
(48.18%) | (84.71%) | (45.53%) | (73.30%) | (90.02%) | (73.26%) | 392.08% | (260.43%) | (192.08%) | (83.61%) |
Average Days of Receivables |
122.66 | 69.99 | 68.05 | 68.89 | 42.79 | 20.72 | 0.00 | 0.00 | — | 0.00 |
Research and Development Expense of Revenue |
123.30% | 242.76% | 610.74% | 203.63% | 74.17% | 145.32% | 188.65% | 851.92% | 0.00% | 21,546.43% |
Selling, General and Administrative Expense of Revenue |
89.86% | 207.74% | 965.36% | 1,967.10% | 670.79% | 1,097.76% | 960.53% | 1,842.40% | 0.00% | 26,710.71% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
25.81% | 53.71% | 240.26% | 220.93% | 81.68% | 163.56% | 163.13% | 265.59% | 0.00% | 2,496.43% |
Graham Net Nets |
(0.14) | (0.51) | (0.06) | (0.37) | (0.71) | (0.94) | (0.07) | 0.50 | — | 0.17 |
Graham Number |
31.57 | 88.20 | 0.00 | 56.16 | 53.15 | 27.96 | 20.72 | 0.00 | — | 0.00 |
Earnings Yield |
(36.86%) | (54.15%) | (35.50%) | (31.75%) | (38.71%) | (51.79%) | 290.99% | (200.00%) | — | (32.46%) |
Free Cash Flow Yield |
(28.66%) | (33.47%) | (22.16%) | (32.71%) | (38.18%) | (47.42%) | (185.32%) | (140.87%) | — | (18.08%) |
Revenue per Share |
7.66 | 3.41 | 0.74 | 0.58 | 1.27 | 0.47 | 0.24 | 0.05 | 0.00 | 0.00 |
Operating CF per Share |
(12.97) | (12.70) | (9.96) | (12.93) | (9.03) | (5.01) | (3.84) | (1.23) | (0.49) | (0.27) |
Capex per Share |
(1.64) | (1.03) | (0.28) | (0.88) | (0.44) | (0.30) | (0.28) | 0.18 | 0.00 | 0.00 |
Free Cash Flow per Share |
(14.62) | (13.72) | (10.24) | (13.80) | (9.47) | (5.31) | (4.11) | (1.04) | (0.49) | (0.27) |
Cash per Share |
35.45 | 25.80 | 36.20 | 16.70 | 10.06 | 7.78 | 2.81 | 0.66 | 0.34 | 0.48 |
Shareholders Equity per Share |
(2.36) | (15.57) | 1.46 | (10.46) | (13.08) | (5.99) | 2.95 | 0.99 | 0.31 | 0.40 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(2.36) | (15.57) | 1.46 | (10.46) | (13.08) | (5.99) | 2.95 | 0.99 | 0.31 | 0.40 |
Free Cash Flow |
(33.11) | (32.17) | (29.89) | (54.65) | (40.36) | (31.83) | (30.38) | (14.87) | (12.68) | (11.36) |
Working Capital |
78.86 | 49.75 | 92.07 | 58.08 | 29.20 | 31.98 | 10.80 | 7.06 | 6.77 | 17.09 |
Capital Expenditures |
(3.72) | (2.40) | (0.82) | (3.47) | (1.85) | (1.83) | (2.05) | 2.62 | — | — |
Net Current Asset Value |
(16.28) | (48.65) | (8.29) | (61.09) | (75.21) | (63.30) | (1.11) | 5.29 | (0.82) | 8.22 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Capex to Sales |
0.21 | 0.30 | 0.38 | 1.52 | 0.34 | 0.65 | 1.16 | (4.03) | — | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.16 | 0.05 | 0.11 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(34.31%) | (74.72%) | (24.51%) | (109.59%) | (447.90%) | (129.70%) | (63.37%) | (63.31%) | (75.21%) | (30.37%) |
Accounts Receivable Turnover |
3.81 | 2.17 | 2.22 | 5.50 | 10.15 | 7.09 | 7.55 | 0.00 | — | 0.00 |
Accounts Payable Turnover |
7.90 | 7.15 | 2.28 | 3.59 | 2.71 | 1.55 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
9.40 | 6.85 | 4.39 | 3.28 | 2.45 | 2.74 | 0.00 | — | — | — |
Average Days of Payables |
46.18 | 48.76 | 190.03 | 92.24 | 165.62 | 206.28 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
63.84 | 32.74 | 78.40 | 176.71 | 98.39 | 108.05 | 165.95 | — | — | — |
Average Receivables |
4.56 | 3.68 | 0.97 | 0.42 | 0.53 | 0.40 | 0.23 | — | — | — |
Average Payables |
1.56 | 1.49 | 1.75 | 1.90 | 2.23 | 2.43 | 1.69 | 1.30 | 1.00 | 0.61 |
Average Inventory |
1.31 | 1.56 | 0.91 | 2.07 | 2.46 | 1.37 | 1.14 | — | — | — |
Average Assets |
113.89 | 87.77 | 98.04 | 105.94 | 78.83 | 72.09 | 62.69 | 33.94 | 19.32 | 23.98 |
Average Common Equity |
13.89 | (20.92) | (16.13) | (18.58) | (48.58) | (45.82) | (7.04) | 17.96 | 11.05 | 12.52 |
Columns are period end dates